Mario Javier Pineda

840 total citations
19 papers, 259 citations indexed

About

Mario Javier Pineda is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mario Javier Pineda has authored 19 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mario Javier Pineda's work include Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (4 papers) and HIV Research and Treatment (3 papers). Mario Javier Pineda is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (4 papers) and HIV Research and Treatment (3 papers). Mario Javier Pineda collaborates with scholars based in United States, Germany and Denmark. Mario Javier Pineda's co-authors include David Morris, Cheryl Y. Brown, Donna L. George, Gregory J. Mize, Julie Overbaugh, Julie Kim, Dan Cao, Zhenxiao Lu, Scott M. Weissman and Kristen J. Vogel Postula and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Mario Javier Pineda

19 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Javier Pineda United States 8 119 99 49 38 34 19 259
J. Liu China 10 149 1.3× 67 0.7× 50 1.0× 45 1.2× 38 1.1× 25 420
Miyuki Matsushita Japan 5 227 1.9× 157 1.6× 31 0.6× 24 0.6× 12 0.4× 11 361
N Tsuruoka Japan 11 133 1.1× 63 0.6× 13 0.3× 35 0.9× 3 0.1× 30 350
Takahide Hayano Japan 12 305 2.6× 38 0.4× 30 0.6× 61 1.6× 2 0.1× 22 414
Kareem Washington United States 12 272 2.3× 57 0.6× 4 0.1× 137 3.6× 56 1.6× 25 442
Francien Talens Netherlands 4 168 1.4× 154 1.6× 15 0.3× 22 0.6× 3 0.1× 6 243
Antonela Merlotti Argentina 7 91 0.8× 49 0.5× 22 0.4× 8 0.2× 3 0.1× 13 217
Dunarel Badescu Canada 7 189 1.6× 65 0.7× 22 0.4× 29 0.8× 4 0.1× 14 286
Charles Joly Beauparlant Canada 9 172 1.4× 25 0.3× 10 0.2× 76 2.0× 4 0.1× 21 258
Luciano Giacò Italy 8 149 1.3× 77 0.8× 25 0.5× 20 0.5× 26 258

Countries citing papers authored by Mario Javier Pineda

Since Specialization
Citations

This map shows the geographic impact of Mario Javier Pineda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Javier Pineda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Javier Pineda more than expected).

Fields of papers citing papers by Mario Javier Pineda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Javier Pineda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Javier Pineda. The network helps show where Mario Javier Pineda may publish in the future.

Co-authorship network of co-authors of Mario Javier Pineda

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Javier Pineda. A scholar is included among the top collaborators of Mario Javier Pineda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Javier Pineda. Mario Javier Pineda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Barber, Emma L., Siqi Chen, Mario Javier Pineda, et al.. (2022). Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium. Cancer Research Communications. 2(10). 1293–1303. 7 indexed citations
2.
Alvarado, Ángel T., et al.. (2022). CYP2D6 and CYP2C19 Genes Associated with Tricontinental and LatinAmerican Ancestry of Peruvians. PubMed Central. 16(1). 14–26. 3 indexed citations
3.
Swetzig, Wendy M., Valery Adorno-Cruz, Mario Javier Pineda, et al.. (2021). Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial. Gynecologic Oncology. 163(1). 57–63. 5 indexed citations
4.
Pineda, Mario Javier, Jeanne M. Schilder, Emily K. Hill, et al.. (2020). A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.. Journal of Clinical Oncology. 38(15_suppl). 6022–6022. 5 indexed citations
5.
Fabbro, Michel, Kathleen N. Moore, Anne Dørum, et al.. (2019). Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial. Gynecologic Oncology. 152(3). 560–567. 32 indexed citations
6.
Swetzig, Wendy M., John R. Lurain, Emily Berry, et al.. (2019). Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.. Journal of Clinical Oncology. 37(15_suppl). 5538–5538. 3 indexed citations
7.
Lord, Rosemary, Mansoor Raza Mirza, Linn Woelber, et al.. (2018). Safety and dose modification for patients with low body weight receiving niraparib in the ENGOT-OV16/NOVA phase III trial. Gynecologic Oncology. 149. 11–11. 2 indexed citations
8.
Kanis, Margaux J., Wenan Qiang, Mario Javier Pineda, Kruti P. Maniar, & Julie Kim. (2018). A small molecule inhibitor of the perinucleolar compartment, ML246, attenuates growth and spread of ovarian cancer. SHILAP Revista de lepidopterología. 5(1). 7–7. 6 indexed citations
9.
Fabbro, Michel, Kathleen N. Moore, Anne Dørum, et al.. (2017). Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC). Annals of Oncology. 28. v332–v332. 7 indexed citations
10.
Chae, Young Kwang, Jonathan F. Anker, Young Suk Kim, et al.. (2017). Abstract 5935: Higher tumor mutation burden (TMB) is associated with the presence of DNA repair gene mutations, T-cell infiltration, and favorable survival outcome in ovarian carcinoma. Cancer Research. 77(13_Supplement). 5935–5935. 2 indexed citations
11.
Postula, Kristen J. Vogel, et al.. (2017). FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices. Journal of Genetic Counseling. 27(1). 131–139. 18 indexed citations
12.
Pineda, Mario Javier, Zhenxiao Lu, Dan Cao, & Julie Kim. (2015). Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth. Hormones and Cancer. 6(4). 131–141. 15 indexed citations
13.
Pineda, Mario Javier & Diljeet K. Singh. (2012). What is Integrative Oncology and Can It Help My Patients?. Obstetrics and Gynecology Clinics of North America. 39(2). 285–312. 6 indexed citations
14.
Pineda, Mario Javier, et al.. (2007). A TRIM5α-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry. Virology. 363(2). 310–318. 23 indexed citations
15.
Celis, José E., Robert G. Flocchini, Omar F. Carvacho, et al.. (2006). Analysis of Aerosol Particles and Coarse Particulate Matter Concentrations in Chillán, Chile, 2001–2003. Journal of the Air & Waste Management Association. 56(2). 152–158. 8 indexed citations
16.
Chihara, Carol J., et al.. (2005). Identification and partial characterization of the enzyme of omega: one of five putative DPP IV genes in Drosophila melanogaster.. Journal of Insect Science. 5(1). 26–26. 8 indexed citations
17.
Pineda, Mario Javier, et al.. (2004). Characterization of virus infectivity and cell‐free capsid assembly of SIVMneCL8. Journal of Medical Primatology. 33(5-6). 262–271. 5 indexed citations
18.
Pineda, Mario Javier, et al.. (2003). Early- and Intermediate-Stage Variants of Simian Immunodeficiency Virus Replicate Efficiently in Cells Lacking CCR5. Journal of Virology. 77(17). 9723–9727. 9 indexed citations
19.
Brown, Cheryl Y., Gregory J. Mize, Mario Javier Pineda, Donna L. George, & David Morris. (1999). Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene. 18(41). 5631–5637. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Liu Breakdown of academic impact, for papers by Miyuki Matsushita Breakdown of academic impact, for papers by N Tsuruoka Breakdown of academic impact, for papers by Takahide Hayano Breakdown of academic impact, for papers by Kareem Washington Breakdown of academic impact, for papers by Francien Talens Breakdown of academic impact, for papers by Antonela Merlotti Breakdown of academic impact, for papers by Dunarel Badescu Breakdown of academic impact, for papers by Charles Joly Beauparlant Breakdown of academic impact, for papers by Luciano Giacò
Rankless by CCL
2026